Abstract Details
|
Ugonma N. Chukwueke, MD
(Dana-Farber Cancer Institute)
PRESENTER |
Dr. Chukwueke has nothing to disclose. |
| Digvijaya D. Navalkele, MD (Emory University) | Dr. Navalkele has nothing to disclose. |
| Marisara Dieppa, MD (University of Texas SW Medical School) | Dr. Dieppa has nothing to disclose. |
| Jaya Trivedi, MD, FAAN (UT Southwestern Medical Center) | The institution of Dr. Trivedi has received research support from Avidity. |
| Tracy T. Batchelor, MD, MPH (Brigham and Women's Hospital) | Dr. Batchelor has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up To Date, Inc. An immediate family member of Dr. Batchelor has received publishing royalties from a publication relating to health care. Dr. Batchelor has received publishing royalties from a publication relating to health care. |
| Jeffrey L. Elliott, MD (UT Southwestern Medical Center) | No disclosure on file |
| Steven Vernino, MD, PhD, FAAN (UT Southwestern Medical Center) | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron. |